Anionic liposomal delivery system for DNA transfection

AAPS Journal

Volumn 6, Issue 4, 2004, Pages

  Patil, Siddhesh D ^a,b   Rhodes, David G ^a   Burgess, Diane J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Antigenics Inc   (United States)

Author keywords

Anionic liposomes; Flow cytometry; Gene delivery; Lipoplex; Nonviral vector; Transfection

Indexed keywords

AMPHOLYTE; ANION; CALCIUM ION; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIOLEOYLPHOSPHATIDYLGLYCEROL; GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; LIPOPLEX; LIPOSOME; PLASMID DNA; PROPIDIUM IODIDE; 1,2 DIOLEOYL GLYCERO 3 PHOSPHATIDYL ETHANOLAMINE; 1,2 DIOLEOYL SN GLYCERO 3 PHOSPHOGLYCEROL; 1,2-DIOLEOYL-GLYCERO-3-PHOSPHATIDYL ETHANOLAMINE; 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOGLYCEROL; CALCIUM; DNA; LIPID; LUMINESCENT AGENT; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DNA TRANSFECTION; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; GENE TARGETING; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; PROTEIN EXPRESSION; STAINING; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; CHO CELL; CRICETULUS; CULTURE MEDIUM; EVALUATION; GENETIC TRANSFECTION; GENETICS; HAMSTER; METABOLISM; PARTICLE SIZE; PLASMID;

ANIMALS; ANIONS; CALCIUM; CHO CELLS; CRICETINAE; CRICETULUS; CULTURE MEDIA; DNA; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; LIPIDS; LIPOSOMES; LUMINESCENT AGENTS; MODELS, BIOLOGICAL; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLGLYCEROLS; PLASMIDS; TRANSFECTION;

EID: 33646663512     PISSN: 15221059     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/aapsj060429     Document Type: Article

References (38)

1. Patil SD, Burgess DJ. DNA-based biopharmaceuticals: therapeutics for the 21st century. AAPS News Magazine. 2003;6:27.
2. Patil SD, Rhodes DG, Burgess DJ. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS PharmSci. 2004; In press.
3. Romano G, Micheli P, Pacilio C, Giordano A. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Stem Cells. 2000;18(1):19-39.
4. Vorburger SA, Hunt KK. Adenoviral gene therapy. Oncologist. 2002;7:46-59.
5. Eastman SJ, Scheule RK. Cationic lipid:pDNA complexes for the treatment of cystic fibrosis. Curr Opin Mol Ther. 1999;1:186-196.
6. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol. 2000;18:33-37.
7. Liu F, Huang L. Development of non-viral vectors for systemic gene delivery. J Control Release. 2002;78(1-3):259-266.
8. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001;7:33-40.
9. Zhdanov RI, Podobed OV, Vlassov VV. Cationic lipid-DNA complexes - lipoplexes - for gene transfer and therapy. Bioelectrochemistry. 2002;58:53-64.
10. Brown MD, Schatzlein AG, Uchegbu IF. Gene delivery with synthetic (non viral) carriers. Int J Pharm. 2001;229(1-2):1-21.
11. Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A. 1987;84:7413-7417.
12. Audouy SA, de Leij LF, Hoekstra D, Molema G. In vivo characteristics of cationic liposomes as delivery vectors for gene therapy. Pharm Res. 2002;19:1599-1605.
13. Marshall J, Yew NS, Eastman SJ, Jiang C, Scheule RK, Cheng SH. Cationic lipid-mediated gene delivery to the airways. In: Huang L, Hung M-C, Wagner E, eds. Nonviral Vectors for Gene Therapy. San Diego, CA: Academic Press; 1999:39-68.
14. Lappalainen K, Jaaskelainen I, Syrjanen K, Urtti A, Syrjanen S. Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res. 1994;11:1127-1131.
15. Dokka S, Toledo D, Shi X, Castranova V, Rojanasakul Y. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm Res. 2000;17:521-525.
16. Filion MC, Phillips NC. Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta. 1997;1329:345-356.
17. Armeanu S, Pelisek J, Krausz E, et al. Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. Mol Ther. 2000;1:366-375.
18. Fillion P, Desjardins A, Sayasith K, Lagace J. Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides. Biochim Biophys Acta. 2001;1515:44-54.
19. Lakkaraju A, Dubinsky JM, Low WC, Rahman Y-E. Neurons are protected from excitotoxic death by p53 antisense oligonucleotides delivered in anionic liposomes. J Biol Chem. 2001;276:32000-32007.
20. Akhtar S, Basu S, Wickstrom E, Juliano RL. Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes). Nucleic Acids Res. 1991;19:5551-5559.
21. Patil SD, Rhodes DG. Influence of divalent cations on the conformation of phosphorothioate oligodeoxynucleotides: a circular dichroism study. Nucleic Acids Res. 2000;28:2439-2445.
22. Perrie Y, Gregoriadis G. Liposome-entrapped plasmid DNA: characterization studies. Biochim Biophys Acta. 2000;1475:125-132.
23. Safinya CR. Structures of lipid-DNA complexes: supramolecular assembly and gene delivery. Curr Opin Struct Biol. 2001;11:440-448.
24. Koltover I, Salditt T, Radler JO, Safinya CR. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science. 1998;281:78-81.
25. Hope MJ, Mui B, Ansell S, Ahkong QF. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs. Mol Membr Biol. 1998;15:1-14.
26. Tilcock CPS, Cullis PR, Gruner SM. Calcium-induced phase separation phenomena in multicomponent unsaturated lipid mixtures. Biochemistry. 1988;27:1415-1420.
27. Xu Y, Szoka FC Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry. 1996;35:5616-5623.
28. Szoka FC Jr, Xu Y, Zelphati O. How are nucleic acids released in cells from cationic lipid-nucleic acid complexes? J Liposome Res. 1996;6:567-587.
29. 2+ and spermine on phosphatidylinositol 4,5-bisphosphate-mediated transmembrane redistribution of phospholipids in large unilamellar vesicles and in erythrocytes. Biochemistry. 1996;35:13345-13352.
30. Williamson P, Kulick A, Zachowski A, Schlegel RA, Devaux PF. Calcium induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry. 1992;31:6355-6360.
31. Bucki R, Bachelot-Loza C, Zachowski A, Giraud F, Sulpice J-C. Calcium induces phospholipid redistribution and microvesicle release in human erythrocyte membranes by independent pathways. Biochemistry. 1998;37:15383-15391.
32. Patil SD, Rhodes DG. Conformation of oligodeoxynucleotides associated with anionic liposomes. Nucleic Acids Res. 2000;28:4125-4129.
33. Merrick P, Nieminen AL, Harper RA, Herman B, Lemasters JJ. Cytotoxicity screening of surfactant-based shampoos using a multiwell fluorescence scanner: correlation with Draize eye scores. Toxicol In Vitro. 1992;6:543-547.
34. Tari AM, Fuller N, Boni LT, Collins D, Rand P, Huang L. Interactions of liposome bilayers composed of 1,2-diacyl-3-succinylglycerol with protons and divalent cations. Biochim Biophys Acta. 1994;1192:253-262.
35. Almofti MR, Harashima H, Shinohara Y, Almofti A, Li W, Kiwada H. Lipoplex size determines lipofection efficiency with or without serum. Mol Membr Biol. 2003;20:35-43.
36. Ross PC, Hui SW. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther. 1999;6:651-659.
37. Turek J, Dubertret C, Jaslin G, Antonakis K, Scherman D, Pitard B. Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection. J Gene Med. 2000;2:32-40.
38. Audouy S, Molema G, De Leij L, Hoekstra D. Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability. J Gene Med. 2000;2:465-476.